The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Thyroid Lobectomy for Papillary Thyroid Cancer: Long‐term Follow‐up Study of 1,088 Cases
Abstract
Background: Total thyroidectomy is well accepted as initial surgery for papillary thyroid cancer (PTC), but the extent of the thyroidectomy remains a matter of controversy. This study was designed to investigate the long‐term clinical outcome of PTC patients who had undergone thyroid lobectomy and to elucidate the indications of lobectomy as initial surgery. Methods: The cases of 1,088 PTC patients who underwent thyroid lobectomy with curative intent at Ito Hospital between 1986 and 1995 were analyzed retrospectively in this study. None of the patients had received postoperative radioactive iodine (RAI) ablation therapy. The median follow‐up period was 17.6 years. All clinical outcomes, including recurrence and death as a result of PTC or other reasons, were evaluated. To establish the indications for lobectomy as initial surgery for PTC, the potential risk factors, such as age, sex, primary tumor size, extrathyroidal invasion, and clinical lymph node metastasis at the time of the initial surgery, were assessed statistically for associations with recurrence and disease‐related death. Results: The remnant‐thyroid recurrence‐free survival (RT‐RFS) rate, the regional‐ lymph‐node recurrence‐free survival (L‐RFS) rate, and the distant‐recurrence‐free survival (D‐RFS) rate as of 25 years after surgery were 93.5, 90.6, and 93.6%, respectively. The cause‐specific survival (CSS) rate at 25 years was 95.2%. Univariate and multivariate analyses showed that none of the factors assessed were significantly associated with the RT‐RFS rate. Tumor size, clinical lymph node metastasis, and extrathyroidal invasion were significantly associated with the L‐RFS rate. The D‐RFS and CSS rates were both significantly lower in the group of patients who were aged 45 years old or older, the group whose tumors were larger than 40 mm, and the group with extrathyroidal invasion. Based on the above findings, we classified the patients into four groups according to age <45 or ≥45 years, tumor size ≤40 or >40 mm, whether clinical lymph node metastasis was present, and whether extrathyroidal invasion was present. None of the patients without any of these four risk factors died of PTC. On the other hand, 22 patients who died of PTC were positive for one or more of these four factors. Conclusions: The long‐term clinical outcome of the PTC patients who had been treated by lobectomy without RAI ablation was excellent. Based on the above results, we concluded that lobectomy is a valid alternative to total thyroidectomy for the treatment of PTC patients who are younger than aged 45 years, whose tumor diameter is 40 mm or less, and who do not have clinical lymph node metastasis or extrathyroidal invasion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.1 · Cited by 8,285
Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Pacini, F., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2009.0110 · Cited by 6,707
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer
Mazzaferri, E. L., & Jhiang, S. M. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90321-2 · Cited by 2,635
Benson, A. B., Abrams, T. A., Ben-Josef, E., Bloomston, P. M., Botha, J. F., Clary, B. M., Covey, A., Curley, S. A., D'Angelica, M. I., Davila, R., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0027 · Cited by 2,268
Pacini, F., Schlumberger, M., Dralle, H., Elisei, R., Smit, J. W. A., Wiersinga, W., & _, _. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02158 · Cited by 1,976
Hundahl, S. A., Fleming, I. D., Fremgen, A. M., & Menck, H. R. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981215)83:12<2638::aid-cncr31>3.0.co;2-1 · Cited by 1,836
HAY, I. D., Bergstralh, E. J., Goellner, J. R., Ebersold, J. R., & Grant, C. S. (1993) · PubMed · Cited by 1,223
An expanded view of risk-group definition in differentiated thyroid carcinoma.
Cady, B., & Rossi, R. (1988) · PubMed · Cited by 937
HAY, I. D., Grant, C. S., Taylor, W. F., & McConahey, W. M. (1987) · PubMed · Cited by 828
Extent of Surgery Affects Survival for Papillary Thyroid Cancer
Bilimoria, K. Y., Bentrem, D. J., Ko, C. Y., Stewart, A. K., Winchester, D. P., Talamonti, M. S., & Sturgeon, C. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e31814697d9 · Cited by 697
Gharib, H., Papini, E., Valcavi, R., Baskin, H. J., Crescenzi, A., Dottorini, M. E., Duick, D. S., Guglielmi, R., Hamilton, C. R., Zeiger, M. A., et al. (2006) · Endocrine Practice · doi:10.4158/ep.12.1.63 · Cited by 681
PAPILLARY THYROID CARCINOMA: THE IMPACT OF THERAPY IN 576 PATIENTS
MAZZAFERRI, E. L., YOUNG, R. L., OERTEL, J. E., KEMMERER, W. T., & PAGE, C. P. (1977) · Medicine · doi:10.1097/00005792-197705000-00001 · Cited by 534
American Association of Clinical Endocrinologists
Ward, R. (2011) · Cited by 483
Prognostic factors in differentiated carcinoma of the thyroid gland
Shah, J. P., Loree, T. R., Dharker, D., Strong, E. W., Begg, C., & Vlamis, V. (1992) · The American Journal of Surgery · doi:10.1016/s0002-9610(05)80729-9 · Cited by 413
Papillary and follicular thyroid cancer
Simpson, W. J., McKinney, S. E., Carruthers, J. S., Gospodarowicz, M. K., Sutcliffe, S. B., & Panzarella, T. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90758-3 · Cited by 382
Sugitani, I., Kasai, N., Fujimoto, Y., & Yanagisawa, A. (2004) · Surgery · doi:10.1016/s0039-6060(03)00384-2 · Cited by 380
An Overview of the Management of Papillary and Follicular Thyroid Carcinoma
MAZZAFERRI, E. L. (1999) · Thyroid · doi:10.1089/thy.1999.9.421 · Cited by 368
AACE/AAES MEDICAL/SURGICAL Guidelines for Clinical Practice: Management of Thyroid Carcinoma
Cobin, R. H., Gharib, H., Bergman, D. A., Clark, O. H., Cooper, D. S., Daniels, G. H., Dickey, R. A., Duick, D. S., Garber, J. R., Hay, I. D., et al. (2001) · Endocrine Practice · doi:10.4158/ep.7.3.202 · Cited by 365
Iyer, N. G., Morris, L. G. T., Tuttle, R. M., Shaha, A. R., & Ganly, I. (2011) · Cancer · doi:10.1002/cncr.26070 · Cited by 321
Impact of Therapy for Differentiated Carcinoma of the Thyroid: An Analysis of 706 Cases*
Samaan, N. A., Maheshwari, Y. K., Nader, S., Hill, C. S., Schultz, P. N., Haynie, T. P., Hickey, R. C., Clark, R. L., Goepfert, H., Ibanez, M. L., et al. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-56-6-1131 · Cited by 270
Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important?
Grant, C. S., HAY, I. D., Gough, I., Bergstralh, E. J., Goellner, J. R., & McConahey, W. M. (1988) · PubMed · Cited by 245
Haigh, P. I., Urbach, D. R., & Rotstein, L. E. (2005) · Annals of Surgical Oncology · doi:10.1007/s10434-004-1165-1 · Cited by 237
Impact on Overall Survival of Radioactive Iodine in Low-Risk Differentiated Thyroid Cancer Patients
Schvartz, C., Bonnetain, F., Dabakuyo, S., Gauthier, M., Cueff, A., Fieffé, S., Pochart, J.-M., Cochet, I., Crevisy, E., Dalac, A., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2512 · Cited by 231
Takami, H., Ito, Y., Okamoto, T., & Yoshida, A. (2011) · World Journal of Surgery · doi:10.1007/s00268-010-0832-6 · Cited by 212
Self-citationFollow-up study of thyroid cancer treated by unilateral lobectomy
Rose, R. G., Kelsey, M. P., Russell, W. O., et al. (1963) · The American Journal of Surgery · doi:10.1016/0002-9610(63)90136-3 · Cited by 61
Cited by
Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., et al. (2016) · Thyroid® · doi:10.1089/thy.2015.0020 · Cited by 16,535
Cabanillas, M. E., McFadden, D. G., & Durante, C. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30172-6 · Cited by 1,430
Guidelines for the management of thyroid cancer
Perros, P., Boelaert, K., Colley, S., Evans, C., Evans, R. M., Gerrard BA, G., Gilbert, J., Harrison, B., Johnson, S. J., Giles, T. E., et al. (2014) · Clinical Endocrinology · doi:10.1111/cen.12515 · Cited by 1,372
Ringel, M. D., Sosa, J. A., Baloch, Z., Bischoff, L., Bloom, G., Brent, G. A., Brock, P. L., Chou, R., Flavell, R. R., Goldner, W., et al. (2025) · Thyroid® · doi:10.1177/10507256251363120 · Cited by 710
Haugen, B. R. (2017) · Cancer · doi:10.1002/cncr.30360 · Cited by 683
Metadata
- Authors
- Matsuzu, K., Sugino, K., Masudo, K., Nagahama, M., Kitagawa, W., Shibuya, H., Ohkuwa, K., Uruno, T., Suzuki, A., Magoshi, S., Akaishi, J., Masaki, C., Kawano, M., Suganuma, N., Rino, Y., Masuda, M., Kameyama, K., Takami, H., & Ito, K.
- Venue
- World Journal of Surgery
- Publisher
- Wiley
- Published
- 2013-10
- Volume
- 38
- Issue
- 1
- Pages
- 68-79
- ISSN
- 0364-2313 (ISSN-L)
- 1432-2323
- OpenAlex
- W2085347450
- Cited by
- 331
- References
- 27
- FWCI
- 11.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.